Features of true acetylcholinesterase (AChE) regulation during growth and differentiation of Friend murine erythroleukemia cells (MELC) have been investigated with respect t o other erythroid and nonerythroid murine elements. Enzyme levels of uninduced MELC were in between the very low AChE contents of erythroid cells and the huge amounts of activity exhibited by megakaryocytes and platelets. After MELC commitment t o terminal division, the enzyme-specific activity increased largely, approaching values that were much closer t o those of thrombocytic than of normal erythroid elements. The bulk of AChE activity in MELC, megakaryocytes, and platelets was found t o be located in the cytosol as a free-soluble form. Moreover, during incubation, MELC actively released large amounts of AChE into the medium, like it occurs in murine thrombocytes. Conversely, the enzyme of the erythroid elements was mainly associated with the membranes and was not released extracellularly.
T linesterase (acetylcholine hydrolase, EC 3.1.
1.7;
AChE) is that of terminating neurotransmission by hydrolyzing acetylcholine at cholinergic synapses in the central and peripheral nervous tissues. However, the enzyme has also been reported in a variety of noncholinergic tissues of several animal species in which it has been suspected to play roles presumably unrelated to neurotransmission.1s2 Indeed, significant amounts of AChE were detected in human erythrocytes3 and T lymphocytes$ murine thrombocytic cells,5,6 WRL-1OA-cultured fibrobla~ts,~ and several erythroleukemia cell line^.^,^ In all these cells, the enzyme might exert alternative and still undetermined catalytic activities possibly acting on substrates different from acetylcho1ine.l
The regulation and role of AChE in noncholinergic systems can be suitably studied in Friend murine erythroleukemia cells (MELC).l0 These are virus-transformed hematopoietic elements, presumably proerythroblasts,ll that can undergo partial maturation to normoblast-like cells when cultured with 1.5% dimethyl sulfoxide (DMSO)" or 5 mmol/L hexamethylene-bisacetamide (HMBA).12 These compounds are known to induce the arrest of cell proliferation and the contemporary expression of hemoglobin and other specialized proteins according to a sequence of events typically encountered in normal erythrop~iesis.'~ AChE, which is a constitutive enzyme of undifferentiated MELC, increases significantly during induced differentiation of HMBA-or DMSO-treated cultures.14 Because the increase in enzyme activity precedes that of hemoglobin, AChE has been proposed as an early marker of differentiation in both the MELC and normal murine erythroid systems. 15 However, in rodents, contrary to what is observed in humans, AChE activity is very low in erythrocytes and quite high in megakaryocytes and platelets,16 for which it represents a distinctive marker.17 Therefore, we decided to investigate the regulation of AChE in MELC and verify Experiments with inducers showed that changes in AChEspecific activity of MELC correlated directly with the arrest of cell proliferation rather than with the activation of differentiated erythroid functions. The inverse relationship existing between MELC growth rates and AChE levels was further supported by the relative enzyme activities of the slow-and fast-growing subclones. We conclude that uninduced MELC potentially share properties of both the erythroid and megakaryoblastic phenotype. The latter might be revealed by typical regulation of AChE activity according t o a thrombocytic-like program activated upon MELC commitment t o terminal division. Eventually, the inhibition of MELC growth by exogenous pure bovine AChE suggested that the secreted murine enzyme might serve as a potential negative signal of cellular replication. o 1992 by The American Society of Hematology.
whether enzyme induction can actually be ascribed to erythroid maturation.
The results of the present study seem to cast doubt on the merely erythroid nature of AChE regulation in MELC, which appeared, conversely, to exhibit the typical enzyme expression of murine megakaryocytic cells.
MATERIALS AND METHODS
MELC (745/A strain; originally obtained by Dr C. Friend and kindly provided by Dr G.B. Rossi, Istituto Superiore di Saniti, Rome, Italy) were grown in suspension using RPMI medium (GIBCO Laboratories, Paisley, UK) supplemented with 5% fetal calf serum (FCS; Boehringer Mannheim, Mannheim, Germany) at 37°C in 6% COz humidified atmosphere. For terminal maturation experiments, cell suspensions (5 to 10 x 104/mL) were incubated for 5 days in the presence of 5 mmol/L HMBA or 1.5% DMSO (Janssen Chimica, Beerse, Belgium). MELC have been also treated with 0.1 mmol/L hemin (Sigma Chemical Co, St Louis, MO) for the same length of time.
Subclones were obtained by limiting dilution of the cell line; isolated clones were then tested for their response to inducers by the benzidine test18 for hemoglobin, as follows. Cells were washed and resuspended with phosphate-buffered saline (PBS) at a density of about 0.75 x 106/mL. Then, 0.1 mLof the suspension was mixed with 50 FL of 0.5 mol/L acetic acid containing 0.2% benzidine and AChE activity was determined spectrophotometrically at 405 nm according to the 5,5'-dithio-bis(-2-nitrobenzoic acid) (DTNB) method19 using 5 mmol/L acetylthiocoline iodide (Boehringer Mannheim) as the substrate. Activity was expressed as milliunits, ie, the amount of enzyme that catalyzes the conversion of 1 nmol/L of acetylthiocoline per minute at 25°C. The enzyme has also been assayed in the presence of 50 pmol/L ethopropazine-HC1 or 10 kmol/L BW284C51 (Sigma), which inhibit true AChE without affecting butyrylcholinesterase activity.
Proteins were determined according to Bradford.20 Cytocentrifugates were prepared on a glass slide by spinning cell suspensions (10 to 20 x lo3 cells/mL) at 1,500 rpm for 10 minutes (Minifuge GL; Heraeus-Christ, Osterode, Germany) at 20°C. Glasses were air-dried and then stained for AChE, without fixation, following the copper-thiocoline method.21 The reagent was freshly prepared and incubated with the slides for 4 to 5 hours at room temperature. Cells were eventually counterstained with Papanicolaou's solution l a (E. Merck, Darmstadt, Germany).
Spleen cell suspensions were obtained from mice (CBA strain) made anemic with phenylhydrazine, as described by Krystal?2 Total spleen cells were separated by centrifugation for 30 minutes at 700g on Ficoll-Paque (Pharmacia, Uppsala, Sweden). Cell populations enriched in erythroblasts and normoblasts were recovered at the interface and bottom of the tube, respectively.
Lymphocytes were recovered after separation of normal spleen cells on Ficoll-Paque and contaminating erythrocytes were eliminated by two cycles of lysis with 0.87% ammonium chloride.
Murine megakaryocytes were collected from bone marrow basically as described by Rabellino et aL' Low-density ( < 1.055 g/mL)
cell fractions, obtained from centrifugation on discontinuous Percoll gradients, were furtherly enriched in megakaryocytes by sedimentation through a discontinuous bovine serum albumin (BSA) gradient (refractive indexes: 1.343/1.340/1.336, from the bottom to the top). The resulting megakaryocyte population (partially contaminated by myeloid cells and occasional eosinophils) was 80% to 85% pure by cell number. Platelets were prepared by differential centrifugation of whole mouse blood collected with 0.2 mol/L Naz EDTA (50 kL/mL whole blood) by cardiac puncture. Platelets were washed free of contaminating plasma proteins through isosmolar 10% arabinogalactan (Stractan; Sigma) according to the method of Hill et al." Mature erythrocytes were obtained from total blood samples pooled after intracardiac punctures of normal mice. Blood cells were centrifuged, as previously described, on Ficoll-Paque and the pellet was lysed in a small volume of 0.87% ammonium chloride to obtain the hemolysate to be assayed for AchE activity, hemoglobin, and total cell proteins. Erythrocyte ghosts were prepared according to the method of Steck and Kant.25 Radiation-induced (RI) cells were transformed lymphocytes derived from a radiation-induced leukemia of the CBA mousez6 obtained from the Chester Beatty Research Institute (London, UK) and passaged in the ascitic form in CBA mice. A tissue culture of RI cells, grown in RPMI plus 5% FCS, was used.
To prepare cell extracts, cells were washed twice with PBS, suspended in 0.5 to 1 mL of 10 mmol/L Tris-HC1 buffer, pH 7.6, containing 0.1% Triton X-100 and 0.5 mmol/L phenylmethylsulphonyl fluoride (PMSF), and sonicated (100 W for 30 seconds) in ice. Extracts were centrifuged at 11,000 rpm for 1 minute (Beckman Minifuge; Beckman Instruments, Palo Alto, CA). For the determination of intracellular AChE distribution, the cytosol was obtained by suspending cells in Triton-free Tris-HCI/PMSF buffer and pelletting the sonicate at 100,OOOg for 30 minutes (Beckman TL-100 Ultracentrifuge). Pellets were then washed once with the same amount of buffer and eventually dissolved in 10 mmol/L Tris-HCUPMSF plus 0.2% Triton X-100. The sample was sonicated once more and then spun down again to collect the clear supernatant. To assess relative distribution of AChE between the cell sap and membrane fraction, enzyme activities were measured in the total extracts and in both the supernatants before and after the addition of the detergent.
The time-course of AChE release by MELC was determined by assaying for enzyme activity in medium samples taken at increasing times of culture within a period of 24 hours.
Pure preparations of AChE from bovine erythrocytes (specific activity, 2,000 mU/mg lyophilisate; Boehringer Manneheim) were used for experiments of MELC growth inhibition.
RESULTS
AChE levels in normal and neoplastic murine hematopoietic cells. AChE-specific activities of both uninduced and induced MELC have been compared with those of other murine erythroid and nonerythroid elements (Table 1) . Uninduced resting MELC contained about 15 mU enzyme/mg protein, while cultures treated for 5 days with 5 mmol/L HMBA or 1.5% DMSO to induce cell terminal division markedly increased their AChE levels up to 70 and 86 mU/mg protein, respectively. Normal immature erythroid elements (erythroblasts and normoblasts, 70% to 80% pure; see Materials and Methods), as well as mature blood erythrocytes, yielded enzyme specific activities within a range of 0.6 to 0.7 mU/mg protein. These facts indicated that: (1) AChE remained virtually constant during normal erythroid maturation from erythroblasts to erythrocytes; and (2) AChE activity in normal erythroid cells was exceedingly lower than that in their neoplastic counterpart, ie, induced MELC.
Among normal cells tested, megakaryocytes and platelets exhibited the highest AChE specific activities (around 400 mU/mg protein), indicating the selectivity of enzyme expression in the thrombocytic versus other hematopoietic lin- The enzyme activity in all of the samples listed above was Fig 1B) were heavily stained, with respect to uninduced cultures (Fig  lA) , because of the presence of many copper grains engulfing the entire cytoplasmic space.
In agreement with these findings, approximately 80% of total AChE activity, from both induced and uninduced MELC (Table 2 ), was readily extracted by homogeneization with 10 mmol/L Tris-HCI buffer, pH 7.4, and concentrated in the postmicrosomal supernate. Some activity (less than 20%) was found to be associated with the particulate fraction (spun down at 100,OOOg) and solubilized with the aid of 0.2% Triton X-100. On the contrary, the bulk of AChE activity in normal murine erythrocytes, taken as the control, appeared to be almost entirely associated with the cell membranes.
Megakaryocytes and platelets did not show such striking differences as above between the soluble and bound AChE, although the amount of free cytosolic activity (around 60%) was still prevalent over that associated with the membrane fraction.
Changes in AChE specijic activity during MELC growth in culture. AChE specific activity (mU/mg protein) was determined in MELC extracts during a 6-day period of culture (Fig 2) . Enzyme levels were steadily around 7 mU/mg protein throughout the logarithmic phase (days 1 through 3). Thereafter, contemporary to the decline of cell growth, AChE specific activity increased progressively, attaining a value of about 23 mU/mg protein at day 6, when culture reached a saturation density of 2.85 X 106/mL. One day after the inoculation of resting cells into fresh medium, AChE levels dropped again to about 7 mU/mg protein.
The inverse relationship existing between intracellular AChE activities and cell growth rates was confirmed by the constitutive enzyme levels of several MELC subclones ( Table 3) . These were isolated and chosen on the basis of their relative mass reached within a 5-day period of culture. Clones attaining a saturation density higher than 4 X lo6 cells/mL were assigned to the so-called fast-growing group. Clones attaining a saturation density lower than 3.2 X lo6 cells/mL were assigned to the so-called slow-growing group. AChE specific activities were found to be significantly lower in fast-growing versus slow-growing MELC subclones.
Effects of inducers of MELC erythroid maturation on AChE levels. Changes in AChE levels were determined in cultures submitted to several inducers of erythroid maturation (Fig 3) . The enzyme reached specific activities of about 70 and 90 mU/mg protein when MELC were treated for 5 days with 5 mmol/L HMBA or 1.5% DMSO, respectively. By the way, DMSO was always found to be more effective than HMBA in raising AChE-specific activity, even though the yield in benzidine-positive MELC was constantly lower. These treatments, as expected, also induced terminal erythroid differentiation, as shown by the increase in benzidinepositive cells and the decrease in cell growth rates. On the tActivity was expressed as the mean f SD of the percentage of total contrary, hemin, which induces erythroid maturation without committing MELC to terminal division,*' did not promote any AChE increase over the control, despite the high percentage of benzidine-positive cells attained.
AChE activity in MELC cultures was not associated only with cells. A significant amount of the enzyme was found to accumulate in the culture medium along with time of incubation. Extracellular accumulation of the enzyme was the result of active secretion, as shown by a time-course experiment (Fig 4,  insert) in which the process appeared to be temperaturedependent, being steadily active at 37°C and inhibited at 4°C. Uninduced MELC released AChE at a constant rate of about 3.4 mU/h/mg cell protein within 12 hours of incubation, accounting for three to four times the intracellular enzyme content. The amount of AChE delivered extracellularly depended closely on time and conditions of culture. Within a 5-day period (Fig 4) , the release of hemin-treated culture was equivalent to the control. DMSO-induced MELC released huge amounts of AChE activity, as compared with control and even with HMBA-induced cells. No significant release of AChE was observed with normal immature erythroid elements from the spleens of anemic mice.
Release of AChE into the medium. Fast-growing Slow-srowina *Subclones isolated from the MELC strain 745A. as reported in Materials and Methods, were gathered into the fast-and slow-growing group on the basis of saturation densities attained in culture (see text).
tEnzyme specific activity was expressed as milliunits of AChE at 25°C per milligram of protein 2 SD and determined after 5 days of culture following the inoculation of 8 x 104 cells/mL RPMl plus 5% FCS. n, the number of clones examined. Inhibition of cell mass increase by pure bovine AChE. Cultures have been incubated with a medium containing increasing amounts of pure bovine AChE. The bovine enzyme was chosen to replace pure murine AChE, which was not commercially available. The aim of the experiment was to monitor the growth of presence of extracellular true 
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resting differentiated cultures. Cell counts indicated that the cell mass increase was progressively inhibited in a dose-dependent manner by the exogenous bovine enzyme. At day 5 of incubation, cultures containing 50,125, and 250 mU AChE/mL of medium attained approximately 84%, 78%, and 45% of control cell mass ( Table 4 ). The inhibitory effect was evident since day 1 of incubation with the enzyme (data not shown) and was not due to cell death, as confirmed by the trypan blue exclusion test performed daily on each culture. It is worth mentioning that in this experiment the amounts of bovine AChE used were not much different than those usually accumulated in a 5-day-old medium of DMSO-induced cultures (100 to 150 mU/mL).
DISCUSSION
MELC have been found to express true AChE activity at levels higher by far than other murine normal and neoplastic hematopoietic cells, apart from megakaryocytes and platelets that are specifically marked by large amounts of the The possibility that MELC AChE might be due to viral infection per se seems to be ruled out by the fact that cultured fibroblasts infected with the Friend virus failed to show appreciable increase in enzyme activity.15 Therefore, we can reasonably assume that AChE represents a constitutive protein of MELC phenotype and that changes in enzyme-specific activity may reflect intrinsic metabolic needs of cells, along with growth and differentiation.
The bulk of AChE activity in MELC was found to be mainly soluble and localized in the cytosol, whereas the significantly lower activities detected in normal erythroid cells were primarily associated with membranes. Such a mirror-like enzyme distribution between MELC and their supposed normal erythroid counterpart suggested that, in these systems, AChE was under the regulation of two completely distinct mechanisms. This hypothesis was supported by the finding that uninduced and especially HMBAor DMSO-induced MELC delivered substantial amounts of AChE into the medium by an active secretory process. The release of AChE is not typical of murine erythroid cells, as we have proved by culturing immature elements from the spleens of anemic mice. Instead, megakaryocytes and platelets are the murine blood elements known to release large quantities of AChE,5 which has been inferred to act in vivo as a regulator of thrombocytic precursor pr~liferation.~~ Moreover, experiments with inducers have clearly indicated that: (1) the induced synthesis of hemoglobin as typically expressed in the erythroid phenotype, and the increase in AChE activity were distinct and largely unrelated metabolic events; and (2) the two processes could be dissected by treating MELC cultures with hemin, which activated differentiated erythroid functions, without affecting either intracellular content or release of AChE.
All these data, together with the reported isolation of MELC subclones, which were prone to AChE increase but not to induced hemoglobin synthesis,15 argue against the hypothesis that the enzyme might serve as a specific marker of erythroid maturation in the mouse. Rather, they point to AChE expression as the result of a megakaryocyte-like program residing in uninduced MELC and enhanced greatly after culture treatments with either HMBA or, particularly, DMSO. These compounds will commit MELC to terminal division and simultaneously promote the activation of multiple differentiated functions, among which hemoglobin synthesis and increase in AChE activity should be regarded as the coexpressed markers of the erythrocytic and megakaryocytic lineages, respectively. As regards these two hematopoietic lineages, it is worth recalling that they may have common p r e c~r s o r s~~; moreover, the existence of burst forming-unit megakaryocytic, erythroid cells (BFU-ME) was proved in the mouse by chromosome analysis of mixed erythroid-megakaryocytic colonies grown in vitro.32 Therefore, it is not unlikely that target cells of virus infection might have been progenitor cells still sharing bipotential or multipotential properties. Actually, the polycytemic strain of Friend virus has been reported to infect either megakaryoblasts or uncommitted hematopoietic elements. 32 The coexpression of multiple markers of distinct hematopoietic lineages has widely been described in leukemia cells.33 This so-called lineage promiscuity is especially evident in human erythroleukemia cell lines HEL34 and K562,35,36 whose differentiated phenotypes express properties of more than one lineage, together with a fairly constant association between erythroid and megakaryoblastoid markers.37 These considerations and results conceming AChE seem to support the view that MELC are not unipotential in terms of their differentiated phenotype, as proposed initially by Marks et al.38 Conversely, the system, although predominantly erythroid, still retains significant megakaryoblastic features related so far to AChE expression and serotonin inc0rporation.3~ Moreover, under suitable culture conditions, MELC may present even some traits of leukopoietic differentiation. 40 The changes in AChE specific activity occurring during MELC growth in culture have disclosed an inverse relationship between enzyme levels and cell proliferation rates. Two additional facts seem to support this finding: (1) slow-growing subclones exhibited constantly higher AChE levels than fast-growing subclones; and (2) large increases in enzyme intracellular levels and release occurred only PAOLElTI, MOCALI, AND VANNUCCHI when MELC differentiation was contemporarily accompanied by induction to terminal division. An increase in AChE activity content and release was reported to occur also in WRL-1OA mouse fibroblasts as soon as they reached high saturation densities in suspension culture^.^ Such a close interaction between components of cholinergic systems and non-neuronal cell growth is consistent with our finding that MELC mass increase was inhibited by exogeneous bovine AChE added to the culture medium. This result supports the suggestion that AChE would actively be synthesized and secreted once MELC growth declines and cells enter their differentiation pathway. The enzyme released might then exert its inhibitory effect on MELC growth acting as a negative autocrine factor. Our conclusions are in line with current hypotheses of cholinergic modulation of murine megakaryocytopoiesis through the interplay of AChE and acetylcholine. In fact, megakaryocyte colonies appeared to be enhanced by both acetylcholine analogs4' and cholinesterase whereas they were decreased by the presence of AChE in the culture medium.43 Moreover, it has also been reported that manipulation of cholinesterase gene expression modulates murine megakaryocytopoiesis in vitro. 44 We believe that the sensitivity of MELC to exogenous AChE might represent remarkable additional evidence that the system retains properties of the normal murine thrombocytic phenotype. This conclusion seems to be supported by the recent finding that thromboxane A2 synthase, an enzyme observed in megakaryocytes and platelets but not in erythroid cells, is induced in activin A-treated MELC.45
